Clinical Trial Update: A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral N-acetylcysteine in children with autism spectrum disorders has been completed. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Autistic Disorder, Asperger Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-06-14